<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

FDA Approves Breyanzi for Previously Treated Large B-Cell Lymphoma

minute read.

Written by Cure Today on June 27, 2022

The FDA approved Breyanzi, a CAR-T cell therapy, for the treatment of certain patients with previously treated large B-cell lymphoma.

Topics: Press Coverage

Comments